Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24

International Journal of Urology

Volumn 13, Issue 4, 2006, Pages 415-419

  Roomi, M Waheed ^a   Ivanov, Vadim ^a   Kalinovsky, Tatiana ^a,b   Niedzwiecki, Aleksandra ^a   Rath, Matthias ^a  

^a Dr Rath Research Institute   (United States)

^b NONE   (United States)

Author keywords

Antitumor effect; Bladder cancer; MMP; Nutrient mixture; T 24

Indexed keywords

ARGININE; ASCORBIC ACID; GELATINASE A; GELATINASE B; GREEN TEA EXTRACT; LYSINE; MATRIGEL; MATRIX METALLOPROTEINASE; PROLINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER CARCINOMA; CANCER CELL; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; EVALUATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ZYMOGRAPHY;

ANTIOXIDANTS; ARGININE; ASCORBIC ACID; CAMELLIA SINENSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HUMANS; LYSINE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PLANT EXTRACTS; PROLINE; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 33744788413     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2006.01309.x     Document Type: Article

References (28)

1. American Cancer Society. Cancer Facts and Figures 2005. American Cancer Society, Atlanta, GA, 2005.
2. Dulaimi E, Uzzo RG, Greenberg RE, Al-Saleem T, Cairns P. Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel. Clin. Cancer Res. 2004 10 : 1887 93.
3. Hudson MA, Herr HW. Carcinoma in situ of the bladder. J. Urol. 1995 153 3 Part 1 564 72.
4. Holmäng S, Hedelin H, Anderström C et al. The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years. J. Urol. 1995 153 : 1823 6 discussion 1826 7.
5. Wahl ML, Moser TL, Pizzo SV. Angiostatin and anti-angiogenic therapy in human disease. Recent Prog. Horm. Res. 2004 59 : 73 104.
6. Oka N, Yamamoto Y, Takahashi M, Nishitani M, Kanayama HO, Kagawa S. Expression of angiopoietin-1 and - 2, and its clinical significance in human bladder cancer. BJU Int. 2005 95 : 660 3.
7. Thrasher JB, Crawford ED. Current management of invasive and metastatic transitional cell carcinoma of the bladder. J. Urol. 1993 149 : 957 72.
8. Fokdal L, Hoyer M, von der Maase H. Treatment outcome and prognostic variables for local control and survival in patients receiving radical radiotherapy for urinary bladder cancer. Acta Oncol. 2004 43 : 749 57.
9. Witte RS, Elson P, Bono B et al. Eastern Cooperative Oncology Group phase II trial of ifosfamide in the treatment of previously treated advanced urothelial carcinoma. J. Clin. Oncol. 1997 15 : 589 93.
10. Sternberg CN, Yagoda A, Scher HI et al. Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse. Cancer 1989 64 : 2448 58.
11. Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin. Exp. Metastasis 1992 10 : 145 55.
12. Rath M, Pauling L. Plasmin-induced proteolysis and the role of apoprotein (a), lysine and synthetic analogs. Orthomol. Med. 1992 7 : 17 23.
13. Netke SP, Roomi MW, Ivanov V, Niedzwiecki A, Rath M. A specific combination of ascorbic acid, lysine, proline and epigallocatechin gallate inhibits proliferation and extracellular matrix invasion of various human cancer cell lines. Res. Commun. Pharmacol. Toxicol. Emerg. Drugs 2003 2 : 37 50.
14. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Antitumor effect of nutrient synergy on human osteosarcoma cells U-2OS, MNNG-HOS and Ewing's sarcoma SK-ES.1. Oncol. Rep. 2005 13 : 253 7.
15. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Synergistic effect of combination of lysine, proline, arginine ascorbic acid, and epigallocatechin gallate on colon cancer cell line HCT 116. JANA 2004 7 : 40 3.
16. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human colon cancer cell HCT 116 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. Oncol. Rep. 2005 13 : 421 5.
17. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. In vivo antitumor effect of ascorbic acid, lysine, proline and green tea extract on human prostate cancer PC-3 xenografts in nude mice: evaluation of tumor growth and immunohistochemistry. In Vivo 2005 19 : 179 83.
18. Roomi MW, Ivanov V, Kalinovsky T, Niedzwiecki A, Rath M. Modulation of N-methyl-N-nitrosourea induced mammary tumors in Sprague-Dawley rats by combination of lysine, proline, arginine, ascorbic acid and green tea extract. Breast Cancer Res. 2005 7 : R291 R295.
19. Albini A, Iwamoto Y, Kleinman HK et al. A rapid in vitro assay for quantitating the invasion potential of tumor cells. Cancer Res. 1987 47 : 3239 45.
20. Almholt K, Lund LR, Rygaard J et al. Reduced metastasis of transgenic mammary cancer in urokinase-deficient mice. Int. J. Cancer 2005 113 : 525 32.
21. Kemberling JK, Hampton JA, Keck RW, Gomez MA, Selman SH. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate. J. Urol. 2003 170 : 773 6.
22. Sato D, Matsushima M. Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl) -nitrosamine in rat by green tea leaves. Int. J. Urol. 2003 10 : 160 6.
23. Naidu KA, Karl RC, Coppola D. Antiproliferative and proapoptotic effect of ascorbyl stearate in human pancreatic cancer cells: association with decreased expression of insulin-like growth factor 1 receptor. Dig. Dis. Sci. 2003 48 : 230 7.
24. Anthony HM, Schorah CJ. Severe hypovitaminosis C in lung-cancer patients: the utilization of vitamin C in surgical repair and lymphocyte related host resistance. Br. J. Cancer 1982 46 : 354 67.
25. Metz N, Lobstein A, Schneider Y et al. Suppression of azoxymethane-induced preneoplastic lesions and inhibition of cyclooxygenase-2 activity in the colonic mucosa of rats drinking a crude green tea extract. Nutr. Cancer 2000 38 : 60 4.
26. Koh WS, Lee SJ, Lee H et al. Differential effects and transport kinetics of ascorbate derivatives in leukemic cell lines. Anticancer Res. 1998 8 : 2487 93.
27. Nunez C, Ortiz de Apodaca Y, Ruiz A. Ascorbic acid in the plasma and blood cells of women with breast cancer. The effect of consumption of food with an elevated content of this vitamin. Nutr. Hosp. 1995 10 : 68 372.
28. Kurbacher CM, Wagner U, Kolster B et al. Ascorbic acid (vitamin C) improves the antineoplastic activity doxorubicin, cisplatin and paclitaxel in human breast carcinoma cells in vitro. Cancer Lett. 1996 103 : 183 9.